Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Fiona Xu"'
Autor:
Min Hu, Yan Wang, En Li, Peter Atadja, Chris Lu, Homan Chan, Xu Wu, Jun Liu, Jing Wu, Qian Li, Shaolian Zhou, Wei Yi, Jingquan Dai, Yanyan Yu, Kehao Zhao, Teddy Yang, Man Zhang, Justin Gu, Youzhen Wang, Ming Fang, Hailong Zhang, Zhaofu Wang, Nathan Englund, Feng Yan, Fiona Xu, Shannon Chuai, Haiping Wu, Zheng Huang
XLSX file, 863K, Lists of differentially expressed genes (DEGs) from comparisons of PAR_TKO and active_inactive groups and overlapping DEGs (p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58cb8a2cc9b8b5e2f8378efd90c1d1eb
https://doi.org/10.1158/0008-5472.22396584
https://doi.org/10.1158/0008-5472.22396584
Autor:
Min Hu, Yan Wang, En Li, Peter Atadja, Chris Lu, Homan Chan, Xu Wu, Jun Liu, Jing Wu, Qian Li, Shaolian Zhou, Wei Yi, Jingquan Dai, Yanyan Yu, Kehao Zhao, Teddy Yang, Man Zhang, Justin Gu, Youzhen Wang, Ming Fang, Hailong Zhang, Zhaofu Wang, Nathan Englund, Feng Yan, Fiona Xu, Shannon Chuai, Haiping Wu, Zheng Huang
XLSX file, 450K, Gene set enrichment analysis (GSEA) reports for comparisons of PAR_TKO and active_inactive groups.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9de81b1e18ce1e9883e61c152e7bb18
https://doi.org/10.1158/0008-5472.22396581
https://doi.org/10.1158/0008-5472.22396581
Autor:
Min Hu, Yan Wang, En Li, Peter Atadja, Chris Lu, Homan Chan, Xu Wu, Jun Liu, Jing Wu, Qian Li, Shaolian Zhou, Wei Yi, Jingquan Dai, Yanyan Yu, Kehao Zhao, Teddy Yang, Man Zhang, Justin Gu, Youzhen Wang, Ming Fang, Hailong Zhang, Zhaofu Wang, Nathan Englund, Feng Yan, Fiona Xu, Shannon Chuai, Haiping Wu, Zheng Huang
PDF file, 153K.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8e747f14e77fc2773ba97bb7d99700
https://doi.org/10.1158/0008-5472.22396590.v1
https://doi.org/10.1158/0008-5472.22396590.v1
Autor:
Min Hu, Yan Wang, En Li, Peter Atadja, Chris Lu, Homan Chan, Xu Wu, Jun Liu, Jing Wu, Qian Li, Shaolian Zhou, Wei Yi, Jingquan Dai, Yanyan Yu, Kehao Zhao, Teddy Yang, Man Zhang, Justin Gu, Youzhen Wang, Ming Fang, Hailong Zhang, Zhaofu Wang, Nathan Englund, Feng Yan, Fiona Xu, Shannon Chuai, Haiping Wu, Zheng Huang
PDF file, 989K, Depletion of NSD2 has only mild effects on myeloma cell proliferation. Supplementary Figure S2. NSD2 is important for tumorigenesis of t(4;14)+ myeloma cells. Supplementary Figure S3. PHD domains are important for cellular H3K36me2 ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fba6655f94ec2d8271115d3f32fdee2
https://doi.org/10.1158/0008-5472.22396593.v1
https://doi.org/10.1158/0008-5472.22396593.v1
Autor:
Min Hu, Yan Wang, En Li, Peter Atadja, Chris Lu, Homan Chan, Xu Wu, Jun Liu, Jing Wu, Qian Li, Shaolian Zhou, Wei Yi, Jingquan Dai, Yanyan Yu, Kehao Zhao, Teddy Yang, Man Zhang, Justin Gu, Youzhen Wang, Ming Fang, Hailong Zhang, Zhaofu Wang, Nathan Englund, Feng Yan, Fiona Xu, Shannon Chuai, Haiping Wu, Zheng Huang
Histone lysine methyltransferase NSD2 (WHSC1/MMSET) is overexpressed frequently in multiple myeloma due to the t(4;14) translocation associated with 15% to 20% of cases of this disease. NSD2 has been found to be involved in myelomagenesis, suggesting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b021285e04af7c6b81bdd5d3bfff4353
https://doi.org/10.1158/0008-5472.c.6504609.v1
https://doi.org/10.1158/0008-5472.c.6504609.v1
Publikováno v:
Quantitative Phase Imaging IX.
Autor:
Bradley Mcgregor, Toni Choueiri, Neil Shah, Aung Bajaj, Jad Chahoud, Bert O’Neil, Joel Michalski, Benjamin Garmezy, Lixian Jin, Usman Aziz, Fiona Xu, Robert Motzer
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Bradley Alexander McGregor, Neeraj Agarwal, Cristina Suárez, Kai Tsao, William Kevin Kelly, Lance C. Pagliaro, Ulka N. Vaishampayan, Daniel Castellano, Yohann Loriot, Fiona Xu, Lana Andrianova, Ramu Sudhagoni, Toni K. Choueiri, Sumanta Monty Pal
Publikováno v:
Journal of Clinical Oncology. 41:684-684
684 Background: In the COSMIC-021 phase 1b study (NCT03170960) evaluating cabozantinib plus atezolizumab in advanced solid tumors, this combination therapy demonstrated encouraging clinical activity in patients with advanced non-clear cell renal cell
Autor:
Fabian Von Arx, Fergal Casey, Sonja Tobler, Robert Cozens, Ying Liang, En Li, E. Robert McDonald, John Monahan, Audrey Kauffmann, Chao Zhang, Hans Bitter, Daniel Wyss, Mallika Singh, Edward Lorenzana, Tara L. Naylor, Francesco Hofmann, Rebecca Leary, Peter Atadja, Alice Loo, Fiona Xu, Anupama Reddy, Hongbo Cai, Ernesta Dammassa, Margaret E. McLaughlin, Shannon Chuai, Yun Zhang, Fernando Salangsang, Susmita Chatterjee, Christian Schnell, Stephanie Barbe, Hui Gao, Michael Rugaard Jensen, Youzhen Wang, Nicholas Keen, William R. Sellers, Millicent Embry, O. Alejandro Balbin, John Green, Marion Wiesmann, Joseph Lehar, Francesca Santacroce, Guizhi Yang, Claudia Roelli, Scott D. Collins, Kavitha Venkatesan, Colleen Kowal, Hui Qin Wang, Montesa Patawaran, Angad P Singh, Jason Merkin, Juliet Williams, Walter Tinetto, Roberto Velazquez, Emma Lees, Stephane Ferretti, Ronald Meyer, Nicolas Ebel, Shawn Cogan, Joshua M. Korn, David A. Ruddy, Zongyao Wang, Yan Tang, Derek Y. Chiang, Nancy Pryer
Publikováno v:
Nature Medicine. 21:1318-1325
Profiling candidate therapeutics with limited cancer models during preclinical development hinders predictions of clinical efficacy and identifying factors that underlie heterogeneous patient responses for patient-selection strategies. We established
Autor:
Kehao Zhao, Ho Man Chan, Haiping Wu, Justin Gu, Jun Liu, Peter Atadja, Jingquan Dai, En Li, Qian Li, Feng Yan, Min Hu, Yan Wang, Zhaofu Wang, Jing Wu, Chris Lu, Youzhen Wang, Zheng Huang, Ming Fang, Xu Wu, Nathan P. Englund, Fiona Xu, Shannon Chuai, Man Zhang, Hailong Zhang, Wei Yi, Shaolian Zhou, Yanyan Yu, Teddy Yang
Publikováno v:
Cancer research. 73(20)
Histone lysine methyltransferase NSD2 (WHSC1/MMSET) is overexpressed frequently in multiple myeloma due to the t(4;14) translocation associated with 15% to 20% of cases of this disease. NSD2 has been found to be involved in myelomagenesis, suggesting